Signaling Pathways - Lck - MK2 - Liver X receptors (LXRs) - eIF4E/eIF3G interaction
清除全部
-
C5545 MK2 Inhibitor IVTarget: MK2Summary: 高选择性、非ATP竞争性MK2抑制剂 -
A8714 SR-9243Target: Liver X receptors (LXRs)Summary: LXR反相激动剂 -
B6962 CMPD-1Target: Microtubules/Tubulins|MK2Summary: p38α介导的MK2a磷酸化的抑制剂 -
B5549 PF-3644022Target: MK2Summary: MK2抑制剂 -
B3696 4EGI-12 CitationTarget: eIF4E/eIF3G interactionSummary: 竞争性的eIF4E/eIF4G相互作用抑制剂。 -
B1264 LXR-6232 CitationTarget: Liver X receptors (LXRs)Summary: 肝X受体激动剂 -
A2249 T0901317Target: Liver X receptors (LXRs)Summary: 肝X受体激动剂 -
A3721 PHA-767491Target: Cyclin-Dependent Kinases|MK2|Cdc7Summary: Cdc7 / CDK9抑制剂 -
A3454 GW39651 CitationTarget: Liver X receptors (LXRs)Summary: 高效选择性HLXRα/hLXRβ激动剂 -
A4113 ZM 447439Target: Aurora Kinases|MEK|Src|LckSummary: Aurora激酶抑制剂